Clinical Trials Logo

Clinical Trial Summary

The prospective multicenter observational cohort study will be offered consecutively to any patient with primary or secondary myelofibrosis or with Polycythemia Vera who has initiated therapy with ruxolitinib, prescribed as part of the normal course of care and completely independent of study participation. The main purpose is to assess adherence to ruxolitinib using the ARMS questionnaire. Each individual patient will be administered the questionnaire at the first convenient opportunity, regardless of when ruxolitinib is started, and again after 4, 8, 12, 24, and 48 weeks, in conjunction with drug procurement.


Clinical Trial Description

The prospective multicenter observational cohort study will be offered consecutively to any patient with primary or secondary myelofibrosis or with Polycythemia Vera who has initiated therapy with ruxolitinib, prescribed as part of the normal course of care and completely independent of study participation. Laboratory tests and histologic, cytogenetic, molecular, and radiologic investigations performed by the patient and collected for study will be conducted in accordance with clinical practice, independent of the patient's participation in the study. In particular, data related to systemic symptoms and splenomegaly will be collected at diagnosis and disease reassessments performed in the context of normal clinical practice. These data will be collected at the first administration of the ARMS questionnaire and again after 12, 24, and 48 weeks. If performed, any additional assessments will also be recorded. Each individual patient will be administered the questionnaire (ARMS) at the first convenient opportunity, regardless of the time of initiation of ruxolitinib, and again after 4, 8, 12, 24, and 48 weeks, in conjunction with drug procurement. If in-person data collection is not possible, the mode of data collection by telephone interview will be adopted. The minimum expected duration of individual patient observation is 48 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06078319
Study type Observational
Source IRCCS Azienda Ospedaliero-Universitaria di Bologna
Contact
Status Completed
Phase
Start date January 18, 2021
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04817176 - MI-CBT Adherence Program for Lifestyle Interventions in Older Adults Early Phase 1
Completed NCT03044145 - The Cultural Formulation Interview-Engagement Aid N/A
Completed NCT03231020 - Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study
Completed NCT03402802 - Steroid Eyedrop Adherence After Trabeculectomy
Recruiting NCT03625674 - Impact of Stigma on Compliance to Medication in Functional Dyspepsia N/A
Active, not recruiting NCT04424368 - Remote Monitoring System for Patients, Who Had Myocardial Infarction N/A
Completed NCT04169646 - Prevention and Intervention of Neck Pain in Swiss Office-Workers N/A
Recruiting NCT03721445 - Could HRV be a Valuable Predictor for CPAP Adherence?
Recruiting NCT05832008 - Increasing Adherence to Lung Cancer Screening N/A
Completed NCT03484637 - Response Evolution Chart
Completed NCT03710213 - Automated Navigation to Improve Outpatient Colonoscopy Adherence N/A
Active, not recruiting NCT04166422 - Virtual Reality and Video Games in Cardiac Rehabilitation Programs N/A
Terminated NCT03109743 - Group Clinical Visit Adherence Intervention for HIV+ Women of Color N/A
Completed NCT03883282 - Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor
Recruiting NCT05709145 - Written Recommendation to Improve Adherence in Poor Bowel Preparation N/A
Not yet recruiting NCT06195839 - Building Engagement Using Financial Incentives Trial - Hypertension N/A
Recruiting NCT05159089 - Physical Activity Drop-out Ratio in Patients Living With Type 2 Diabetes N/A
Completed NCT06068699 - Postcards to Improve Remote Monitoring Adherence Among Veterans N/A
Completed NCT03340428 - Post-release Retention in HIV Care for Ex-inmates in South Africa N/A
Recruiting NCT05613010 - Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant N/A